Physician

Robert Samuel Wirthlin, M.D.

According to 2025 Medicare claims, Robert Wirthlin, M.D. (NPI: 1013973254) practices ophthalmology in the Spokane-Spokane Valley, WA market, with the plurality of this provider's patient population coming from Spokane, WA. This provider's primary affiliated billing organization is SPOKANE EYE CLINIC PS (NPI: 1730187899; TIN: 910852217) and primary practice location at 99204-2509.

Wirthlin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 757 traditional Medicare patients, billed 69,239 HCPCS/CPT codes, and received $3,977,547 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 643 prescription claims across 190 beneficiaries totaling $34,547 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 199 records totaling $471,846. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.0M2015 Medicare payment: $3,010,631 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,764,047 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,809,641 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,966,993 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,579,028 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,670,576 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,738,393 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,767,208 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,757,385 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,977,547 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201586814,752$3,010,631
201679714,305$2,764,047
201779313,296$2,809,641
201884413,399$2,966,993
201997314,719$3,579,028
202080913,105$3,670,576
202183613,905$3,738,393
202287319,238$3,767,208
202375154,560$3,757,385
202475769,239$3,977,547

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$35K$70K2015 Drug cost: $28,010 (USD; Tot_Drug_Cst)2016 Drug cost: $32,989 (USD; Tot_Drug_Cst)2017 Drug cost: $43,959 (USD; Tot_Drug_Cst)2018 Drug cost: $46,017 (USD; Tot_Drug_Cst)2019 Drug cost: $57,081 (USD; Tot_Drug_Cst)2020 Drug cost: $69,892 (USD; Tot_Drug_Cst)2021 Drug cost: $53,795 (USD; Tot_Drug_Cst)2022 Drug cost: $42,004 (USD; Tot_Drug_Cst)2023 Drug cost: $34,910 (USD; Tot_Drug_Cst)2024 Drug cost: $34,547 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015158484$28,010
2016147463$32,989
2017155550$43,959
2018187653$46,017
2019207702$57,081
2020192688$69,892
2021184556$53,795
2022187554$42,004
2023175584$34,910
2024190643$34,547

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1631,724$644
67028Injection of drug into eye3682,091$91
92014Established patient complete exam of visual system389426$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more203285$65
92134Imaging of retina7452,756$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1536,446$6,648
IlevroNepafenac16421$5,755
DifluprednateDifluprednate421,455$5,650
Atropine SulfateAtropine Sulfate983,525$2,869
Ketorolac TromethamineKetorolac Tromethamine351,131$1,555

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$22,762Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.166$449,085Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.1$7,384US Retina LLC

FAQ

What Medicare data is available for Robert Samuel Wirthlin, M.D.?

Tedicare shows public-source Medicare data for Robert Samuel Wirthlin, M.D. (NPI 1013973254), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Samuel Wirthlin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Samuel Wirthlin, M.D.?

Robert Samuel Wirthlin, M.D. is linked to SPOKANE EYE CLINIC PS (billing NPI 1730187899) in the available physician profile data.

Does Robert Samuel Wirthlin, M.D. have Open Payments data?

Robert Samuel Wirthlin, M.D. has 199 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.